Literature DB >> 19389515

Antitumor efficacy induced by human ovarian cancer cells secreting IL-21 alone or combination with GM-CSF cytokines in nude mice model.

Jun Dou1, Yongfang Wang, Jing Wang, Fengshu Zhao, Yating Li, Minggang Cao, Weihua Hu, Kai Hu, Xiang Feng He, Lili Chu, Chuilian Jiang, Ning Gu.   

Abstract

The ovarian cancer cells (SKOV3) secreting IL-21 alone or combination with GM-CSF cytokines was developed and its antitumor effect was evaluated in the nude mice. The gene of IL-21 was amplified from plasmid pRSC-IL-21 by PCR, cloned into the plasmid pRSC-GM-CSF, and the plasmid pRSC-GM-CSF-IL21 was constructed. The plasmids of pRSC-GM-CSF, pRSC-IL21, pRSC-GM-CSF-IL21 and pRSC were respectively transfected into the SKOV3 cells and antitumor efficacy induced by the SKOV3 cells secreting IL-21 or combination with GM-CSF was evaluated by surveying the tumor growth and the nude mice's survival. The results indicated that the secreted IL-21 and GM-CSF were functional because the culture supernatant of SKOV3 cells transfected with the plasmid pRSC-GM-CSF-IL21 enhanced NK cytotoxicity in vitro. The expressions of MIC A/B, NKG2D and ICAM-1 molecules on the SKOV3 cells were up-regulated. The level of IFN-gamma and TNF-alpha, the NK cytotoxicity and the antitumor efficacy were significantly increased in the null mice inoculated with the SKOV3 cells secreting both IL-21 and GM-CSF in comparison with the nude mice inoculated with the other different SKOV3 cells. We concluded that the SKOV3 cells genetically engineered to secrete biologically active IL-21 and GM-CSF elicited antitumor immunity effectively through enhancing NK cytotoxicity, promoting the expressions of MIC A/B , ICAM-1 and NKG2D molecules as well as elevating level of IFN-gamma and TNF-alpha in the nude mice model.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19389515     DOI: 10.1016/j.imbio.2008.11.002

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  10 in total

1.  Antitumor efficacy induced by a B16F10 tumor cell vaccine treated with mitoxantrone alone or in combination with reserpine and verapamil in mice.

Authors:  Xiangfeng He; Jing Wang; Jun Dou; Fangliu Yu; Kai Cai; Xiaoli Li; Hongyi Zhang; Ning Gu
Journal:  Exp Ther Med       Date:  2011-06-14       Impact factor: 2.447

2.  Synergistic effects of soluble PD-1 and IL-21 on antitumor immunity against H22 murine hepatocellular carcinoma.

Authors:  Xiu-Cheng Pan; Li Li; Juan-Juan Mao; Wei Yao; Jun-Nian Zheng; Mei Liu; Juan-Juan Fu
Journal:  Oncol Lett       Date:  2012-10-12       Impact factor: 2.967

3.  Current and Futuristic Roadmap of Ovarian Cancer Management: An Overview.

Authors:  Orlandric Miree; Sanjeev Kumar Srivastava; Santanu Dasgupta; Seema Singh; Rodney Rocconi; Ajay Pratap Singh
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 4.  Immune response in ovarian cancer: how is the immune system involved in prognosis and therapy: potential for treatment utilization.

Authors:  Nikos G Gavalas; Alexandra Karadimou; Meletios A Dimopoulos; Aristotelis Bamias
Journal:  Clin Dev Immunol       Date:  2011-01-24

Review 5.  IL-21: a pleiotropic cytokine with potential applications in oncology.

Authors:  Michela Croce; Valentina Rigo; Silvano Ferrini
Journal:  J Immunol Res       Date:  2015-04-15       Impact factor: 4.818

6.  Gene therapy of ovarian cancer using IL-21-secreting human umbilical cord mesenchymal stem cells in nude mice.

Authors:  Yunxia Zhang; Jing Wang; Mulan Ren; Miao Li; Dengyu Chen; Junsong Chen; Fangfang Shi; Xiaoying Wang; Jun Dou
Journal:  J Ovarian Res       Date:  2014-01-20       Impact factor: 4.234

7.  Iron Oxide Nanoparticles Combined with Cytosine Arabinoside Show Anti-Leukemia Stem Cell Effects on Acute Myeloid Leukemia by Regulating Reactive Oxygen Species.

Authors:  Jun Dou; Luoyang Li; Mei Guo; Feng Mei; Danfeng Zheng; Hui Xu; Rui Xue; Xueyang Bao; Fengshu Zhao; Yu Zhang
Journal:  Int J Nanomedicine       Date:  2021-02-17

8.  Effect of targeted ovarian cancer immunotherapy using ovarian cancer stem cell vaccine.

Authors:  Di Wu; Jing Wang; Yunlang Cai; Mulan Ren; Yuxia Zhang; Fangfang Shi; Fengshu Zhao; Xiangfeng He; Meng Pan; Chunguang Yan; Jun Dou
Journal:  J Ovarian Res       Date:  2015-10-24       Impact factor: 4.234

Review 9.  Recent Progress in Gene Therapy for Ovarian Cancer.

Authors:  Ángela Áyen; Yaiza Jiménez Martínez; Juan A Marchal; Houria Boulaiz
Journal:  Int J Mol Sci       Date:  2018-06-30       Impact factor: 5.923

10.  The Assessment of IL-21 and IL-22 at the mRNA Level in Tumor Tissue and Protein Concentration in Serum and Peritoneal Fluid in Patients with Ovarian Cancer.

Authors:  Aleksandra Mielczarek-Palacz; Celina Kruszniewska-Rajs; Marta Smycz-Kubańska; Jarosław Strzelczyk; Wojciech Szanecki; Andrzej Witek; Joanna Magdalena Gola
Journal:  J Clin Med       Date:  2021-07-09       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.